title: Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease.
abstract: Several allelic mutations at the arylsulfatase A (ASA) locus cause substantial deficiencies of this lysosomal enzyme. Depending on the genetically determined degree of the deficiency, the clinical outcome may be very different--either metachromatic leukodystrophy (MLD), a lethal lysosomal storage disorder affecting the nervous system, or, more frequently, the so-called pseudodeficiency (PD), which has no apparent clinical consequence. Because of compound heterozygosity for MLD and PD, 1/1,000 individuals in the population have low residual enzyme activities, which are intermediate between those of MLD patients and those of PD homozygous normal individuals. In order to assess whether PD/MLD compound heterozygotes bear a health risk, we examined clinically and biochemically 16 individuals with this genotype. Of these subjects, two had neurological symptoms and two showed lesions, without clinical symptoms, in magnetic resonance imaging of the brain. None of these symptoms was progressive, nor did they resemble those of MLD. Nerve conduction velocities were normal in these probands, and they secreted only low amounts of sulfatide in the urine. We conclude that the observed neurological symptoms are unrelated to the ASA genotype and that PD/MLD compound heterozygotes are not at an increased risk for developing progressive nervous system diseases.
authors.affiliation: Department of Pediatrics, University of Berne, Switzerland.
authors.forename: J M
authors.initials: JM
authors.lastname: Penzien
authors.forename: J
authors.initials: J
authors.lastname: Kappler
authors.forename: N
authors.initials: N
authors.lastname: Herschkowitz
authors.forename: B
authors.initials: B
authors.lastname: Schuknecht
authors.forename: P
authors.initials: P
authors.lastname: Leinekugel
authors.forename: P
authors.initials: P
authors.lastname: Propping
authors.forename: T
authors.initials: T
authors.lastname: Tønnesen
authors.forename: H
authors.initials: H
authors.lastname: Lou
authors.forename: H
authors.initials: H
authors.lastname: Moser
authors.forename: S
authors.initials: S
authors.lastname: Zierz
mesh_terms: D000293:Adolescent; D000328:Adult; D000483:Alleles; D001921:Brain / Q000473:pathology; D002553:Cerebroside-Sulfatase / Q000172:deficiency* / Q000235:genetics*; D002675:Child, Preschool; D005260:Female; D006580:Genetic Carrier Screening; D005838:Genotype; D006801:Humans; D007966:Leukodystrophy, Metachromatic / Q000235:genetics* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009422:Nervous System Diseases / Q000175:diagnosis* / Q000473:pathology; D014057:Tomography, X-Ray Computed
chemical_list: D002553:Cerebroside-Sulfatase